This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kalman, B Articles by Alder, H Search for Related Content PubMed Articles by Kalman, B Articles by Alder, H Social Bookmarking                         What's this?

Mitochondrial DNA mutations in multiple sclerosis

Department of Neurology

FD Lublin

Department of Neurology

H Alder

Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA

The presence of mitochondrial DNA mutations, including eight of those frequently associated with Leber's hereditary optic neuropathy (LHON), was investigated by sequencing end restriction endonuclease analysis in randomly selected patients with MS. Class I LHON mutations with primary pathogenic significance for blindness were not detected in any of the MS patients studied. A trend was observed for higher frequency of class II LHON mutations with unknown pathogenic significance in the MS patients than in the controls. Specifically, the mutation at position 4216 and its associated simultaneous mutations occurred with a higher frequency. Eleven of the 53 patients (20.8%) were positive for at least two (4216 and 4917 or 13708) or three (4216, 13 708, 15 257) simultaneous class II LHON mutations, white 7 of the 74 controls (9.5%) carried simultaneous mutations (P=0.036). Earlier studies reported the occurrence of either the 11 778 or 3460 LHON type mutations in MS patients with a positive LHON pedigree and/or with a disease course predominantly involving the optic nerves. The mutations we detected did not correlate with the severity of visual loss in either LHON or MS, rather they seemed to be present in randomly selected MS patients. We conclude that the mutations with primary pathogenic significance for blindness are not shared between LHON and randomly selected MS. However, the presence offurther mitochondrial mutations cannot be excluded in MS. The increased incidence of the simultaneous class II LHON mutations in MS patients (and LHON) vs controls may indicate that certain sets of mitochrondrial DNA mutations/variants are associated with and predispose to MS, a possibility which needs to be investigated further. Alternatively, a biological disadvantage may be associated with the coexistence of the mutations detected.

Key Words: genetic susceptibility • mitochrondrial DNA mutations

Multiple Sclerosis, Vol. 1, No. 1, 32-36 (1995)
DOI: 10.1177/135245859500100106


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Love Establishing preconditions for Balo's concentric sclerosis Brain, May 1, 2005; 128(5): 960 - 962. [Full Text] [PDF]

				B. Kalman, F. D Lublin, and H. Alder Impairment of central and peripheral myelin in mitochondrial diseases Multiple Sclerosis, January 1, 1997; 2(6): 267 - 278. [Abstract] [PDF]

				B. Kalman, J. L. Rodriguez-Valdez, U. Bosch, and F. D Lublin Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis Multiple Sclerosis, January 1, 1997; 2(6): 279 - 282. [Abstract] [PDF]

				B Kalman, H Alder, U. Bosch, F. Lublin, and D Chatterjee The evolutionary relationship among Caucasian MS patients and controls Multiple Sclerosis, April 1, 1996; 1(5): 288 - 295. [Abstract] [PDF]